HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+3.78%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$274M
AUM Growth
+$274M
(-2.4%)
Cap. Flow
+$1.08M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
29.37%
Holding
164
New
33
Increased
27
Reduced
41
Closed
27
Top Buys
| 1 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
$4.39M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
$4.25M |
| 3 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
$4.02M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$2.22M |
| 5 |
Salesforce
CRM
|
$2.19M |
Top Sells
| 1 |
SP
SP Plus Corporation
SP
|
$4.12M |
| 2 |
Orthofix Medical
OFIX
|
$2.44M |
| 3 |
Nuvalent
NUVL
|
$2.38M |
| 4 |
Immunocore
IMCR
|
$2.26M |
| 5 |
IDEAYA Biosciences
IDYA
|
$2.05M |
Sector Composition
| 1 | Healthcare | 43.71% |
| 2 | Technology | 17% |
| 3 | Consumer Discretionary | 6.54% |
| 4 | Energy | 4.11% |
| 5 | Consumer Staples | 3.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Enliven Therapeutics
ELVN
$1.24B
| $2.8M | 1.02% |
119,789
-7,065
| -6% | -$165K |
|
27
XPO
XPO
$14.8B
| $2.7M | 0.99% |
25,480
-12,900
| -34% | -$1.37M |
|
28
Olema Pharmaceuticals
OLMA
$432M
| $2.68M | 0.98% |
247,880
| – | – |
|
29
Spyre Therapeutics
SYRE
$1.02B
| $2.67M | 0.98% |
113,550
-40,831
| -26% | -$960K |
|
30
Viridian Therapeutics
VRDN
$1.59B
| $2.58M | 0.94% |
198,484
| – | – |
|
|
BCYC
31
Bicycle Therapeutics
BCYC
$492M
| $2.58M | 0.94% |
127,255
-31,038
| -20% | -$628K |
|
32
Capri Holdings
CPRI
$2.51B
| $2.57M | 0.94% |
77,700
| – | – |
|
33
Vaxcyte
PCVX
$4.17B
| $2.44M | 0.89% |
32,313
+22,992
| +247% | +$1.74M |
|
34
Cogent Biosciences
COGT
$1.83B
| $2.37M | 0.87% |
281,093
| – | – |
|
35
Visa
V
$681B
| $2.34M | 0.86% |
8,927
| – | – |
|
36
Fiserv
FI
$74.3B
| $2.32M | 0.85% |
15,553
+2,900
| +23% | +$432K |
|
|
37
Teva Pharmaceuticals
TEVA
$21.5B
| $2.22M | 0.81% |
+136,500
| New | +$2.22M |
|
|
38
Nuvalent
NUVL
$5.74B
| $2.18M | 0.8% |
28,698
-31,313
| -52% | -$2.38M |
|
39
Alphabet (Google) Class C
GOOG
$2.79T
| $2.1M | 0.77% |
11,436
-900
| -7% | -$165K |
|
40
T-Mobile US
TMUS
$284B
| $2.1M | 0.77% |
11,900
+2,400
| +25% | +$423K |
|
41
Meta Platforms (Facebook)
META
$1.85T
| $2.06M | 0.75% |
4,090
-400
| -9% | -$202K |
|
42
PTC
PTC
$25.4B
| $1.92M | 0.7% |
10,581
+3,200
| +43% | +$581K |
|
|
SWTX
43
DELISTED
SpringWorks Therapeutics
SWTX
| $1.92M | 0.7% |
50,987
| – | – |
|
44
MoonLake Immunotherapeutics
MLTX
$3.78B
| $1.86M | 0.68% |
42,249
-17,520
| -29% | -$770K |
|
45
Seagate
STX
$37.5B
| $1.84M | 0.67% |
17,800
+5,000
| +39% | +$516K |
|
|
AUTL
46
Autolus Therapeutics
AUTL
$383M
| $1.81M | 0.66% |
518,820
+257,496
| +99% | +$896K |
|
47
Travere Therapeutics
TVTX
$1.75B
| $1.8M | 0.66% |
219,416
| – | – |
|
48
Equity Residential
EQR
$24.7B
| $1.8M | 0.66% |
25,900
+4,000
| +18% | +$277K |
|
49
Keros Therapeutics
KROS
$640M
| $1.79M | 0.65% |
39,208
| – | – |
|
50
Western Digital
WDC
$29.8B
| $1.79M | 0.65% |
23,600
+3,800
| +19% | +$288K |
|